Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
Biol Psychiatry. 2010 Jun 15;67(12):1191-8. doi: 10.1016/j.biopsych.2010.01.025. Epub 2010 Mar 17.
It has frequently been hypothesized that high levels of glucocorticoids have deleterious effects on the hippocampus and increase risk for cognitive decline and dementia, but no large-scale studies in humans have examined the direct relation between hippocampal volumes and hypothalamic-pituitary-adrenal axis activity.
Cross-sectional analyses within the Second Manifestations of ARTerial disease-Magnetic Resonance (SMART)-Medea study, an ancillary study to the SMART-MR study on brain changes on magnetic resonance imaging (MRI) among patients with arterial disease. In 575 patients (mean age 62 +/- 9 years), diurnal cortisol rhythm was assessed with six saliva samples, collected at awakening; at 30, 45, and 60 min thereafter; and at 10 pm and 11 pm. A low dose of dexamethasone (.5 mg) was administered at 11 pm, and saliva was sampled the next morning at awakening. Volumetric measurements of the hippocampus were performed on a three-dimensional fast field echo T1-weighted scan with isotropic voxels.
Mean total relative hippocampal volume was 6.0 +/- .7 mL. Linear regression analyses, adjusted for age, sex, vascular risk factors, and global brain atrophy showed that participants with higher evening levels and higher awakening levels after dexamethasone had smaller hippocampal volumes [B per SD (4.2) increase = -.09 mL; 95% confidence interval -.15 to -.03 mL and B per SD (2.5) increase = -.07 mL; 95% confidence interval -.13 to -.01 mL, respectively]. The awakening response was not significantly associated with hippocampal volumes.
In this population, higher evening cortisol levels and reduced suppression after dexamethasone were associated with smaller hippocampal volumes, independent of total brain volume. The cortisol response after awakening was not associated with hippocampal volume.
人们经常假设,高水平的糖皮质激素对海马体有有害影响,并增加认知能力下降和痴呆的风险,但人类尚未进行大规模研究来检查海马体体积与下丘脑-垂体-肾上腺轴活动之间的直接关系。
在动脉疾病的磁共振成像(MRI)脑改变的 SMART-MR 研究的辅助研究——第二表现的动脉疾病-Magnetic Resonance(SMART)-Medea 研究中,进行了横断面分析。在 575 名患者(平均年龄 62 +/- 9 岁)中,通过在六个唾液样本中评估日间皮质醇节律,这些样本在唤醒时采集;此后 30、45 和 60 分钟采集;晚上 10 点和 11 点采集。晚上 11 点给予低剂量地塞米松(.5 毫克),并在第二天早上唤醒时采集唾液样本。使用具有各向同性体素的三维快速场回波 T1 加权扫描对海马体进行容积测量。
平均总相对海马体体积为 6.0 +/-.7 mL。经年龄、性别、血管危险因素和全脑萎缩调整的线性回归分析显示,夜间水平较高和地塞米松后唤醒水平较高的参与者的海马体体积较小[每标准差(4.2)增加量为 -.09 毫升;95%置信区间为 -.15 至 -.03 毫升和每标准差(2.5)增加量为 -.07 毫升;95%置信区间为 -.13 至 -.01 毫升]。唤醒反应与海马体体积无显著相关性。
在该人群中,夜间皮质醇水平较高和地塞米松后抑制作用降低与海马体体积较小有关,与总脑体积无关。唤醒后的皮质醇反应与海马体体积无关。